Compare Hinge Health Inc. Class A Common Stock (HNGE) vs VF Corp (VFC) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Hinge Health Inc. Class A Common Stock vs VF Corp — how do they compare? Hinge Health Inc. Class A Common Stock trades at $104.95 (market cap $8.47B), while VF Corp trades at $16.49 (market cap $6.48B). The key difference: Hinge Health Inc. Class A Common Stock is the larger of the two by market cap, and VF Corp pays a 2.18% dividend while Hinge Health Inc. Class A Common Stock pays none. Which is the better fit depends on your goals — on Pluang, investors hold Hinge Health Inc. Class A Common Stock for 0 Days and VF Corp for 64 Days on average.
| HNGE | VFC | |
|---|---|---|
Market Cap | $8.47B | $6.48B |
Volume | 1,624,526 | 18,946,837 |
Sector | Health | Consumer Cyclical |
52-Week High | $105.14 | $21.55 |
52-Week Low | $31.17 | $12.62 |
Typical Hold Time | 0 Days | 64 Days |
Enterprise Value | $8.09B | $10.76B |
Dividend Yield | — | 2.18% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Hinge Health (HNGE) trades at $105.14, up 0.31% on the day and near its 52-week high. The stock shows strong analyst support with a 93.75% buy rating, though the current price exceeds the consensus target of $101.62. Recent earnings beat expectations in two of the last three quarters, with Q3 2026 results due November 2. Fundamentals indicate robust revenue growth projections from $588 million in 2025 to $720 million in 2026, alongside a shift to profitability, but valuation multiples like EV/EBITDA at 82.33 remain elevated.
The outlook is cautiously optimistic given projected profitability and expansion into migraine and GI care, but risks include high insider selling, competitive pressures, and the stock's premium valuation. Execution on growth targets and Q3 earnings will be critical for sustaining momentum.
VFC trades at $16.07, up 1.77% today, with a bullish technical signal from moving averages despite overbought RSI readings. The company reported mixed quarterly results, beating in Q4 2025 but missing in subsequent quarters, while revenue declined to $9.5B in 2025 with a net loss of $189.72M. Analyst consensus shows a Hold rating with a $18.33 price target, and the company recently announced a $0.09 dividend for September 2026.
VFC presents a turnaround opportunity with discounted valuation metrics (P/S 0.67) and improving cash flow projections for 2026, but faces significant execution risks from Vans brand weakness and high debt levels. The stock's near-term performance hinges on Q3 2026 earnings delivery and sustained outdoor segment growth offsetting core brand challenges.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Hinge Health Inc. Class A Common Stock
Hinge Health Inc. operates a digital musculoskeletal (MSK) care platform that delivers exercise therapy for joint and muscle conditions through health plans and employers. Its Precision Motion Technology combines wearable sensors and computer vision to guide patients through clinician-directed physical therapy remotely.
Read more on HNGE →About VF Corp
VF designs, produces, and distributes branded apparel and accessories. Its largest apparel categories include action sports, outdoor, and workwear. Its portfolio of about a dozen brands includes Vans, The North Face, Timberland, Supreme, and Dickies. VF markets its products in the Americas, Europe, and Asia-Pacific through wholesale sales to retailers, e-commerce, and branded stores owned by the company and partners. The company has grown through multiple acquisitions and traces its roots to 1899.
Read more on VFC →
